Key Points Interested in iShares Biotechnology ETF? Here are five stocks we like better. The iShares Nasdaq Biotechnology ETF ...

The heart-drug developer sent a new signal to biotech investors about what Wall Street is willing to fund in 2026. That is ...

Biotech is now the deepest pocket of leadership in the entire Nasdaq. Everyone can see biotech is moving, and the why is ...

Nasdaq has long been the home for biotech companies, and this past January, National Biotechnology Month proved no different. The sector was active with five healthcare companies raising $800 million ...

Biotech investors, executives and analysts worry that blanket bans on deals with Chinese companies could curb domestic ...

Biotech stocks are considered extremely high-risk, high-reward investments. Many biotech companies are developing one or more ...

Microsoft has backed out of building data centers, Intel's factory opening has been delayed to 2030, but one tech industry is going strong in central Ohio: Biotechnology. The now multibillion dollar ...

Three mid-cap biotechs have become prime acquisition targets, but only one offers what big pharma is hunting for most.

Biotech and biopharma companies choose names that cluster around certain letters in the alphabet - here's what they are, and ...